B. Avouac

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men (2006)

REGINSTER, JY, ABADIE, E, DELMAS, P, RIZZOLI, R, DERE, W, DER AUWERA, P, ...

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis (2005)

Altman, RD, Abadie, E, Avouac, B, Bouvenot, G, Branco, J, Bruyère, Olivier, ...

Objective: The Group for the Respect of Ethics and Excellence in Science (GREES) organized a working group to assess the value of time to joint surgery as a potential therapeutic failure outcome...

Guidelines for clinical studies assessing the efficacy of drugs for the management of acute low back pain (2004)

DEVOGELAER, J, DREISER, R, ABADIE, E, AVOUAC, B, BOUVENOT, G, CARBONELL, A, ...

The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis. (2002)

DELMAS, PD, CALVO, G, BOERS, M, ABADIE, E, AVOUAC, B, KAHAN, A, ...

Background for studies on the treatment of male osteoporosis: state of the art. (2000)

Kaufman, Jean, JOHNELL, O, ABADIE, E, ADAMI, S, AUDRAN, M, AVOUAC, B, ...

Do estrogens effectively prevent osteoporosis-related fractures? (2000)

REGINSTER, JY, BRUYERE, O, AUDRAN, M, AVOUAC, B, BODY, JJ, BOUVENOT, G, ...

Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis. (1999)

Kaufman, Jean, COMPSTON, J, AUDRAN, MA, AVOUAC, B, DEVOGELAER, JP, LEMMEL, EM, ...

Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis. (1998)

LEMMEL, EM, REID, DM, NUKI, G, AVOUAC, B, BARDIN, T, BOUVENOT, G, ...

Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules (1998)

STEVENSON, JC, GASPARD, U, AVOUAC, B, BRICAIRE, C, CARDOZO, L, COLLINS, P, ...

Recommendations for the registration of drugs used in the treatment of osteoarthritis. (1996)

DOUGADOS, M, DEVOGELAER, JP, ANNEFELDT, M, AVOUAC, B, BOUVENOT, G, COOPER, C, ...

Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis. (1996)

COMPSTON, JE, AUDRAN, M, AVOUAC, B, BOUVENOT, G, DEVOGELAER, JP, EASTELL, R, ...

Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis. (1995)

REGINSTER, J, COMPSTON, J, JONES, E, Kaufman, Jean, AUDRAN, M, BOUVENOT, G, ...

Background for studies on the treatment of male osteoporosis: state of the art

Kaufman, J, Johnell, O, Abadie, E, Adami, S, Audran, M, Avouac, B, ...

Male osteoporosis represents an important, although long underestimated, public health problem. Both in men and in women aging is accompanied by continuous bone loss and by an exponential increase in...

Primary osteoarthritis and occupations: a national cross sectional survey of 10 412 symptomatic patients

Rossignol, M, Leclerc, A, Hilliquin, P, Allaert, F, Rozenberg, S, Valat, J, ...

Aims: To describe the age standardised prevalence of symptomatic osteoarthritis (OA) in a nationwide cross sectional survey of 10 412 patients in France, and their functional and work limitations.

Primary osteoarthritis of hip, knee, and hand in relation to occupational exposure

Rossignol, M, Leclerc, A, Allaert, F, Rozenberg, S, Valat, J, Avouac, B, ...

Aim: To identify occupations with excess prevalence of osteoarthritis of the knee, hip, and hand in a nationwide survey and to compare occupations with and without excess prevalence with regard to...